31.05.2017
- US drugmaker Merck has bought an exclusive global licence from Japan’s Teijin Pharma to develop, manufacture and commercialize an investigational preclinical antibody candidate...
06.03.2017
- Britain's health agency National Institute for Health and Care Excellence (NICE), which has responsibility for assessing the cost-effectiveness of medical treatments, has decided...
24.02.2017
- In a letter to the leadership of the US Congress, 16 CEOs of major American companies, including Pfizer’s Ian Read, Eli Lilly’s David Ricks, Merck & Co’s Ken Frazier and Celgene’s...
01.02.2017
- In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...
24.01.2017
- US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...
13.01.2017
- American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...
12.01.2017
- More than 350 companies headquartered or with operations in the US, including such diverse enterprises as Monsanto, Genentech, Unilever, L’Oreal USA and the Merck Family Fund...
03.01.2017
- Indian pharmaceutical company Zydus Cadila has acquired six brands from US drugmaker Merck for an undisclosed sum. The branded products are anabolic steroids Deca-Durabolin and...
